NewAmsterdam Pharma Company N.V.

NAMS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$27.49-1.08%

2026-08-03

Financials

Valuation Metrics

NewAmsterdam Pharma Company N.V.'s Market Cap is $3.21B. At end of 2025 it was $4.01B. Ranked #1711 of 3,112 in US market (top 55%), #611 of 1,445 on NASDAQ (top 42%), #102 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 38%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$3.21B	US#1,711/3,112 Sec#102/269
Revenue	$23M	US#2,899/3,112 Sec#170/269
Net Income	$-213M	US—/3,112 Sec—/269
Total Assets	$733M	US#2,584/3,112 Sec#120/269
Net Assets	$665M	US#2,054/3,112 Sec#81/269
Value
P/B	4.83x	US#2,145/3,112 Sec#138/269
P/S	142.42x	US#2,919/3,112 Sec#186/269
FCF Yield	-4.42%	US—/3,112 Sec—/269
Profitability
ROE	-31.98%	US#2,631/3,112 Sec#132/269
ROA	-29.04%	US#2,865/3,112 Sec#160/269
Op. Margin	-953.59%	US#2,918/3,112 Sec#176/269
Revenue Growth	2.08%	US#2,035/3,112 Sec#119/269
Financial Health
Debt Ratio	10.14%	US#114/3,112 Sec#50/269
Total Debt	$23000.00	US#2,973/3,112 Sec#263/269
FCF	$-142M	US#2,670/3,112 Sec#184/269
Cash	$458M	US#1,122/3,112 Sec#59/269
Current Ratio	9.76x	US#258/3,112 Sec#80/269
Performance
1Y Return	29.18%	US#1,287/3,112 Sec#151/269
1M Return	-21.07%	US#2,965/3,112 Sec#237/269
From 52W High	-34.87%	US#2,358/3,112 Sec#178/269
1Y MDD	-33.68%	US#1,617/3,112 Sec#105/269
Trading
Volume	993,747 shares	US#1,470/3,112 Sec#145/269
Trading Value	$27M	US#1,795/3,112 Sec#128/269
Per Share
EPS	$-1.78	US—/3,112 Sec—/269
BPS	$5.97	US#2,133/3,112 Sec#116/269